- Home
- IDYA vs TRMD Comparison
IDYA vs TRMD Comparison
Compare IDYA & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- TRMD
- Stock Information
- Founded
- IDYA 2015
- TRMD 1889
- Country
- IDYA United States
- TRMD United Kingdom
- Employees
- IDYA N/A
- TRMD N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- TRMD Marine Transportation
- Sector
- IDYA Health Care
- TRMD Consumer Discretionary
- Exchange
- IDYA Nasdaq
- TRMD Nasdaq
- Market Cap
- IDYA 1.9B
- TRMD 1.7B
- IPO Year
- IDYA 2019
- TRMD N/A
- Fundamental
- Price
- IDYA $21.23
- TRMD $16.72
- Analyst Decision
- IDYA Strong Buy
- TRMD Buy
- Analyst Count
- IDYA 13
- TRMD 1
- Target Price
- IDYA $53.42
- TRMD $23.00
- AVG Volume (30 Days)
- IDYA 1.1M
- TRMD 934.0K
- Earning Date
- IDYA 08-05-2025
- TRMD 08-14-2025
- Dividend Yield
- IDYA N/A
- TRMD 23.97%
- EPS Growth
- IDYA N/A
- TRMD N/A
- EPS
- IDYA N/A
- TRMD 4.74
- Revenue
- IDYA $7,000,000.00
- TRMD $1,444,200,000.00
- Revenue This Year
- IDYA $101.20
- TRMD N/A
- Revenue Next Year
- IDYA $286.70
- TRMD N/A
- P/E Ratio
- IDYA N/A
- TRMD $3.52
- Revenue Growth
- IDYA N/A
- TRMD N/A
- 52 Week Low
- IDYA $13.45
- TRMD $13.60
- 52 Week High
- IDYA $44.42
- TRMD $40.47
- Technical
- Relative Strength Index (RSI)
- IDYA 62.23
- TRMD 47.97
- Support Level
- IDYA $21.08
- TRMD $17.19
- Resistance Level
- IDYA $22.37
- TRMD $19.41
- Average True Range (ATR)
- IDYA 0.92
- TRMD 0.53
- MACD
- IDYA -0.09
- TRMD -0.07
- Stochastic Oscillator
- IDYA 61.72
- TRMD 18.50
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.